Willis Towers Watson said revenue for Q2 2025 was $2,261 million, flat compared to $2,265 million in the prior-year period on a reported basis (0%), and increased 5% on an organic basis. The company cited the sale of TRANZACT as the reason revenue was flat.

1. 01

   Willis Towers Watson said revenue for Q2 2025 was $2,261 million, flat compared to $2,265 million in the prior-year period on a reported basis (0%), and increased 5% on an organic basis. The company cited the sale of TRANZACT as the reason revenue was flat.

2. 02

   The company said income from operations for Q2 was $368 million, up 74% from $212 million in the prior-year period, operating margin was 16.3% (up 690 basis points), and adjusted operating margin was 18.5% (up 150 basis points).

3. 03

   Willis Towers Watson said diluted earnings per share for Q2 was $3.32, compared to $1.36 in the prior-year period (up 144%), adjusted diluted earnings per share was $2.86, compared to $2.39 in the prior-year period (up 20%), and net income was $332 million.

4. 04

   The company said free cash flow for the 6 months ended June 30, 2025 was $217 million, a decrease of $88 million from $305 million in the prior-year period, and repurchased 1,614,427 shares for $500 million during Q2.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.